EFFECT OF PREGNANCY ON THE DISPOSITION OF VALPROATE IN RATS

被引:8
作者
KOBAYASHI, S
TAKAI, K
IGA, T
HANANO, M
机构
[1] UNIV TOKYO HOSP,DEPT PHARM,BUNKYO KU,TOKYO,JAPAN
[2] UNIV TOKYO,FAC PHARMACEUT SCI,BUNKYO KU,TOKYO 113,JAPAN
来源
JOURNAL OF PHARMACOBIO-DYNAMICS | 1990年 / 13卷 / 09期
关键词
disposition; non-linear kinetics; tissue distribution; valproate;
D O I
10.1248/bpb1978.13.533
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The disposition of sodium valproate in pregnant rats was studied comparing with nonpregnant (control) rats. In the pregnant rats, the total plasma clearance decreased significantly (p<0.05) from 7.06 ml/min/kg of the control to 5.34 ml/min/kg, whereas the plasma elimination half-life of valproate did not change. The serum unbound fraction (fs) of pregnant rats increased remarkably. The fs of the fetal plasma was lower than that of the maternal serum in spite of the lower albumin (main binding protein for valproate) concentration in the fetal plasma. A non-linear serum (plasma) protein binding was observed both in the control and the fetal rats, but not observed in the pregnant rats. In the pregnant rats, the tissue-to-plasma concentration ratio (Kp) of the brain was higher than that in the control rats, whereas the Kp values of the liver and lung were lower than those in the control rats. In other tissues, the Kp values did not show a significant difference. Rapid placental transfer was observed and the K value of the fetus was 0.43. © 1990, The Pharmaceutical Society of Japan. All rights reserved.
引用
收藏
页码:533 / 542
页数:10
相关论文
共 44 条
[21]  
HALAC E, 1969, J LAB CLIN MED, V73, P677
[22]   PHYSIOLOGICALLY BASED PHARMACOKINETICS OF VALPROIC ACID IN RABBITS [J].
ICHIMURA, F ;
DEGUCHI, Y ;
YOKOGAWA, K ;
YAMANA, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 27 (01) :45-60
[23]   DRUG KINETICS IN PREGNANCY [J].
KRAUER, B ;
KRAUER, F .
CLINICAL PHARMACOKINETICS, 1977, 2 (03) :167-181
[24]   METABOLISM OF BRANCHED MEDIUM CHAIN-LENGTH FATTY-ACID .1. OMEGA-OXIDATION OF SODIUM DIPROPYLACETATE IN RATS [J].
KUHARA, T ;
MATSUMOTO, I .
BIOMEDICAL MASS SPECTROMETRY, 1974, 1 (04) :291-294
[25]  
LEVY G, 1976, EFFECT DISEASE STATE, P137
[26]  
LEVY G, 1975, CLIN PHARMACOL THER, V38, P210
[27]  
LIN JH, 1983, J PHARMACOL EXP THER, V225, P653
[28]   METABOLISM OF BRANCHED MEDIUM CHAIN-LENGTH FATTY-ACID .2. BETA-OXIDATION OF SODIUM DIPROPYLACETATE IN RATS [J].
MATSUMOTO, I ;
KUHARA, T ;
YOSHINO, M .
BIOMEDICAL MASS SPECTROMETRY, 1976, 3 (05) :235-240
[29]  
NANBO T, 1982, J PHARMACOBIO-DYNAM, V5, P213
[30]   ANTI-CONVULSANTS DURING PREGNANCY AND LACTATION - TRANS-PLACENTAL, MATERNAL AND NEONATAL PHARMACOKINETICS [J].
NAU, H ;
KUHNZ, W ;
EGGER, HJ ;
RATING, D ;
HELGE, H .
CLINICAL PHARMACOKINETICS, 1982, 7 (06) :508-543